This is associated with the mechanism of action of bevacizumab: the hypertension induced by bevacizumab mainly results from increased peripheral vascular resistance caused by VEGF signal blockade, rather than organic cardiorenal damage, so it is highly controllable (21). This evidence concerns the gene VEGFA and Hypertension.